Columbia University Irving Medical Center

What Columbia University Irving Medical Center does

Columbia University Irving Medical Center (CUIMC) is the academic medical center of Columbia University, a private Ivy League institution founded in 1767 and headquartered at 630 West 168th Street in Washington Heights, New York. CUIMC operates as a non-profit clinical, research, and educational enterprise comprising four professional schools (Vagelos College of Physicians and Surgeons, Mailman School of Public Health, School of Nursing, and College of Dental Medicine), the ColumbiaDoctors multi-specialty physician practice with over 2,000 physicians across 250+ specialties, and research institutes including the Irving Institute for Clinical and Translational Research and the NCI-designated Herbert Irving Comprehensive Cancer Center. The institution's research footprint spans AI diagnostics, genomics, gene therapy, CAR-T cell therapy, RNA therapeutics, focused ultrasound, brain-computer interfaces, and advanced surgical techniques including multivisceral transplantation.

CUIMC's revenue model rests on three primary streams: patient care services delivered through ColumbiaDoctors and the affiliated NewYork-Presbyterian Hospital; research grants from federal agencies (notably five consecutive NIH CTSA grants totaling $288 million since 2006, with a $75 million award in 2026) and industry-sponsored clinical trials; and tuition from degree programs across the four professional schools. The institution serves patients seeking complex and specialty care, medical and health sciences students, research sponsors and industry collaborators (including Novartis and IAEA), and referring physicians and healthcare networks requiring specialty expertise. Technology transfer is handled through Columbia Technology Ventures, with notable recent innovations including the AI-powered STAR sperm recovery system, ultra-sensitive CD70-targeted CAR-T cells, an injectable RNA therapy for heart repair, and an AI method for predicting peak oxygen consumption in advanced heart failure patients.

Name

Columbia University Irving Medical Center

Legal name

Columbia University Irving Medical Center

Website

https://cuimc.columbia.edu

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Columbia University Irving Medical Center is an Ivy League academic medical center operating four health science schools, the ColumbiaDoctors multi-specialty physician practice with 2,000+ physicians, and NIH-funded research institutes, serving patients, medical students, and research sponsors in the New York metro area.

Ownership category

akta.pro rank

Product category

Academic Medical Center

NAICS

General Medical and Surgical Hospitals (622110), General Medical and Surgical Hospitals (62211), General Medical and Surgical Hospitals (6221), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Colleges, Universities, and Professional Schools (6113), Medical and Diagnostic Laboratories (6215)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Health Services (8000)

akta.pro primary industry

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA)

akta.pro secondary industries

Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

Keywords

• Academic medical center
• Medical education
• Clinical care services
• Biomedical research
• Health sciences training

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Patient Care Services: Clinical care revenue generated through ColumbiaDoctors, the multi-specialty physician practice covering all major medical and surgical specialties. Services include primary care (Columbia Primary Care), specialty care, cancer care (Herbert Irving Comprehensive Cancer Center), children's health, dentistry, and digital health services. Patients include those with complex conditions referred nationally and internationally.
2. Research Grants and NIH Funding: Substantial research funding from federal agencies including the NIH. The Irving Institute for Clinical and Translational Research was awarded $75 million CTSA grant in 2026, representing the fifth consecutive CTSA grant totaling $288 million in NIH funding since 2006. Additional funding comes from industry-sponsored clinical trials and foundation grants.
3. Academic Programs and Tuition: Revenue from educational programs across four schools: Vagelos College of Physicians and Surgeons, Mailman School of Public Health, School of Nursing, and College of Dental Medicine. Programs include MD, PhD, MPH, MS, and other graduate degrees, with tuition and associated fees as a funding stream.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Columbia University Irving Medical Center (CUIMC) is the academic medical center of Columbia University, operating a unified clinical enterprise (ColumbiaDoctors with over 2,000 physicians across 250+ specialties), four health science schools (VP&S, Mailman School of Public Health, School of Nursing, College of Dental Medicine), and major research institutes including the NIH-funded Irving Institute for Clinical and Translational Research and the NCI-designated Herbert Irving Comprehensive Cancer Center.

Product overview

Columbia University Irving Medical Center (CUIMC) is a comprehensive academic medical center consisting of a unified clinical enterprise ColumbiaDoctors (including primary care, specialty care, and dental services) and four health science schools (Vagelos College of Physicians and Surgeons, Mailman School of Public Health, School of Nursing, and College of Dental Medicine). Research operations span institutes including the Irving Institute for Clinical and Translational Research (CTSA-funded with $75M), Herbert Irving Comprehensive Cancer Center (NCI-designated), Columbia Clinical Innovation Lab, and Columbia Technology Ventures. Patient care services include Columbia Primary Care, Columbia Fertility Center (utilizing proprietary STAR AI technology for IVF), Children's Health, and ColumbiaDoctors Dentistry. The institution operates digital health infrastructure and maintains research affiliations with NewYork-Presbyterian Hospital.

Differentiator

Problem solved

Functional benefit

Brands

• Columbia Fertility Center: Fertility treatment center offering AI-powered reproductive technologies including STAR system for sperm tracking and recovery
• Columbia Clinical Innovation Lab
• Columbia Technology Ventures
• The Louisa Gross Horwitz Prize

Products and services

• ColumbiaDoctors Multi-specialty physician practice providing comprehensive patient care across all medical and surgical specialties, serving as the primary clinical care delivery arm for CUIMC.
• Columbia Primary Care Primary care physician network providing preventive care, health maintenance, and treatment of acute and chronic conditions for adult and pediatric patients.
• Herbert Irving Comprehensive Cancer Center NCI-designated comprehensive cancer center providing cancer research, prevention, diagnosis, and treatment services, including CAR-T therapy, gene therapies, and access to clinical trials.
• Columbia University Fertility Center Fertility treatment center utilizing AI-powered STAR technology for sperm identification and IVF procedures, including treatment for azoospermia and other infertility conditions.
• Children's Health Services Pediatric healthcare services including general pediatrics, pediatric subspecialties, and children's research programs for pediatric patients.
• ColumbiaDoctors Dentistry Dental practice offering comprehensive oral healthcare services through the College of Dental Medicine faculty practice.
• Digital Health Services at Columbia Digital health services including patient portal, telemedicine, and health IT infrastructure supporting care coordination across Columbia healthcare facilities.
• Vagelos College of Physicians and Surgeons Medical school providing MD education, residency, fellowship training, and conducting biomedical research, training the next generation of physician leaders.
• Mailman School of Public Health Graduate school of public health offering MPH, MS, and doctoral programs, conducting research in epidemiology, environmental health, health policy, and global health.
• Columbia School of Nursing School of nursing providing undergraduate, graduate, and doctoral nursing education and conducting nursing research, training nurse clinicians and researchers.
• College of Dental Medicine Dental school providing DDS education, advanced specialty training, and oral healthcare services, training dentists and dental specialists.
• Irving Institute for Clinical and Translational Research NCATS CTSA-funded institute driving translational science, supporting clinical research infrastructure, AI tools, community partnerships, training programs, and federated learning infrastructure.
• Columbia Clinical Innovation Lab Research and innovation hub for clinical technologies and AI in healthcare delivery, testing new approaches to patient care.
• Columbia Technology Ventures Technology transfer office managing intellectual property, patents, and licensing of Columbia University innovations to industry partners.
• Clinical Trials Clinical trials program offering experimental treatments across multiple therapeutic areas, accessible to patients nationally and internationally who meet eligibility criteria.

Quantifiable outcome

• Ultra-sensitive CAR-T cells successfully eliminated kidney, ovarian, and pancreatic tumors in mice with 10-50x greater sensitivity than existing cellular therapies
• +4 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability16 records

Feature5 records

Partnerships

15 partnerships are on record, tiered core, major and minor.

• NewYork-Presbyterian HospitalcoreStrategic or Co-development PartnerNewYork-Presbyterian is the primary affiliated hospital for Columbia University Irving Medical Center. Columbia faculty physician Emily Tat holds roles at both institutions. The partnership provides inpatient clinical facilities for Columbia's physicians, enabling integrated patient care, clinical trials, and medical education.
• Weill Cornell MedicinecoreStrategic or Co-development PartnerMulti-institutional research collaboration including Weill Cornell Medicine, Cornell Tech, Cornell Ann S. Bowers College of Computing and Information Science, Columbia University Vagelos College of Physicians and Surgeons, and NewYork-Presbyterian developed an AI-powered method for predicting peak oxygen consumption in heart failure patients.
• Cornell Tech and Cornell Ann S. Bowers College of Computing and Information SciencecoreTechnology or IntegrationCornell institutions partnered with Columbia on the development of AI diagnostic tools for advanced heart failure, providing computational and data science expertise.
• NovartiscoreStrategic or Co-development PartnerThe Pakistan Genome Resource, one of the largest genomic studies in South Asia, was conducted by Novartis, Columbia University Irving Medical Center, and the Center for Non-Communicable Diseases in Karachi. 173,303 participants were examined, identifying over 6.6 million coding genetic variants, informing drug development.
• Center for Non-Communicable Diseases in KarachicoreStrategic or Co-development PartnerCollaborated with Columbia and Novartis on the Pakistan Genome Resource, a major genomic study examining 173,303 Pakistani participants to identify genetic variants relevant to disease susceptibility and drug development.
• UNC (University of North Carolina)majorStrategic or Co-development PartnerPart of a multi-institutional study (with Duke, Oxford, Columbia, and University of Miami) examining FDA-authorized AI-driven clinical devices. The study found that 43% of 521 devices lacked publicly available clinical validation data, spurring creation of an independent evaluation research network.
• Duke UniversitymajorStrategic or Co-development PartnerPart of multi-institutional study with UNC, Oxford, Columbia, and University of Miami examining AI clinical device validation, finding 43% of 521 FDA-authorized AI devices lack clinical validation data.
• University of OxfordmajorStrategic or Co-development PartnerPart of multi-institutional study with UNC, Duke, Columbia, and University of Miami examining AI clinical device validation across 521 FDA-authorized AI-driven clinical devices.
• University of MiamimajorStrategic or Co-development PartnerPart of multi-institutional study with UNC, Duke, Oxford, and Columbia examining AI clinical device validation, highlighting the need for independent evaluation infrastructure for clinical AI.
• Beth Israel Deaconess Medical CentermajorStrategic or Co-development PartnerPeter Brodeur of Beth Israel Deaconess Medical Center is co-building with Columbia (Emily Tat) a research network to provide independent evaluation infrastructure for clinical AI, addressing the gap that neither the FDA nor the market has addressed.
• International Atomic Energy Agency (IAEA)majorStrategic or Co-development PartnerIAEA-coordinated international study on radiation doses from cardiac imaging analyzed data from over 19,000 patients at 742 centers in 101 countries, with Columbia University providing methodological leadership. Study published in JAMA.
• New York Academy of SciencesmajorStrategic or Co-development PartnerCo-hosted the 3rd annual 'New Wave of AI in Healthcare' symposium on May 12-13 with Icahn School of Medicine at Mount Sinai, bringing together researchers, clinicians, and industry leaders to discuss AI's role in healthcare.
• Icahn School of Medicine at Mount SinaimajorStrategic or Co-development PartnerCo-hosted the 3rd annual 'New Wave of AI in Healthcare' symposium with the New York Academy of Sciences, discussing AI in healthcare delivery, diagnostics, drug discovery, and clinical support tools.
• DeGregorio Family FoundationminorOthersAwarded $500,000 Michael F. Price Memorial Grant ($250,000 directly, with $250,000 from Torrey Coast Foundation) to Dr. Timothy C. Wang at Columbia for developing novel gastroesophageal cancer therapy TFF2-MSA.
• Torrey Coast FoundationminorOthersCo-contributed $250,000 to the $500,000 Michael F. Price Memorial Grant awarded to Dr. Timothy C. Wang at Columbia for gastroesophageal cancer research.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• UCSF Health: University of California San Francisco's academic medical enterprise. Comparable in NIH research funding, multi-specialty clinical services, and graduate medical education; competes for research talent and pharma partnerships on the West Coast.
• Mount Sinai Health System: NYC academic medical center with Icahn School of Medicine, eight hospital campuses, and major research enterprise. Direct peer for clinical referrals, research collaborations (joint AI symposium), and faculty recruitment; competing for patients across all five boroughs.
• Mass General Brigham: Harvard-affiliated academic medical system combining Massachusetts General Hospital and Brigham and Women's Hospital. Comparable scale, top-tier research funding (similar NIH profile), multi-specialty clinical enterprise, and serves as benchmark for peer AMC operations nationally.
• Johns Hopkins Medicine: Johns Hopkins University School of Medicine and health system. Comparable AMC structure combining leading medical school, NIH-funded research, and clinical enterprise; similarly strong in CAR-T and gene therapy research and a national benchmark for academic medicine.
• NYU Langone Health: Direct competitor academic medical center in NYC combining medical school (NYU Grossman), research enterprise, and multi-specialty clinical practice. Comparable in scale, scope of specialties, and patient demographic, and competes for the same NYC patient pool and faculty talent.
• Weill Cornell Medicine: Cornell University's medical school and affiliated NewYork-Presbyterian campus. Operates a parallel AMC structure with comparable research capabilities, and is an active research collaborator (AI cardiac prediction partnership) as well as a competitor for patients and faculty.
• Penn Medicine (University of Pennsylvania): University of Pennsylvania's AMC combining Perelman School of Medicine, research enterprise, and clinical system. Strong peer for CAR-T research (Abramson Cancer Center) and gene therapy, with comparable NIH funding profile and translation focus.
• Duke University Health System: Duke University's academic medical enterprise combining School of Medicine, research institute, and clinical system. Direct peer for NIH-funded clinical AI research (joint study on FDA-authorized AI device validation) and clinical trial infrastructure.
• NewYork-Presbyterian Hospital: CUIMC's primary clinical affiliate that provides inpatient hospital facilities for Columbia's faculty physicians. While structurally distinct, the two institutions are operationally intertwined as New York's largest AMC partnership and compete jointly against other NY academic systems.

Regional players

• Memorial Sloan Kettering Cancer Center: NYC-based specialty cancer hospital that overlaps with Columbia's Herbert Irving Comprehensive Cancer Center in oncology research and patient referrals. While not a full AMC, MSKCC competes for cancer patients and translational oncology talent in the same geography.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/columbiamed
• Facebookfacebook.com/columbiamed

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Columbia University Irving Medical Center